Interview: Mary Bailey: Managing Director: Last Prisoner Project

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Latest News

NEWS: Psilocybin Could Help Prevent Debilitating Nerve Damage Caused by Chemotherapy

HCN News Team2026-09-07T23:31:41-08:00September 7th, 2026|

AUSTIN – A new study from The University of Texas MD Anderson Cancer Center suggests that psilocybin, the psychedelic compound found in certain mushrooms, could eventually help prevent one of chemotherapy’s most painful and persistent side ...

Elixinol Offloads Its US Hemp Business to Ananda Health

HCN News Team2026-09-07T08:08:11-08:00September 7th, 2026|

SYDNEY – Australian Elixinol Wellness Limited has entered into a binding asset purchase agreement with Ananda Health to sell its wholly-owned subsidiary, Elixinol LLC, effectively exiting the United States hemp market. Under the transaction terms, ...

ARPA-H Launches ASCENT-IBO Initiative for Ibogaine Clinical Research

HCN News Team2026-09-07T06:29:35-08:00September 7th, 2026|

WASHINGTON – The Advanced Research Projects Agency for Health (ARPA-H) has launched a federal research opportunity aimed at accelerating clinical evaluations of ibogaine for Opioid Use Disorder (OUD). Titled ASCENT-IBO, short for Accelerating Safe Clinical ...